Jane Street
HUMA icon

Jane Street’s Humacyte HUMA Stock Holding History

Jane Street’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$270K Buy
445,100
+398,600
+857% +$414K ﹤0.01% 9456
2025
Q4 		$44.7K Sell
46,500
-21,500
-32% -$30.4K ﹤0.01% 10539
2025
Q3 		$118K Sell
68,000
-36,300
-35% -$71.1K ﹤0.01% 10050
2025
Q2 		$218K Buy
104,300
+35,400
+51% +$68K ﹤0.01% 8400
2025
Q1 		$117K Buy
68,900
+45,500
+194% +$171K ﹤0.01% 8732
2024
Q4 		$118K Sell
23,400
-90,500
-79% -$448K ﹤0.01% 8697
2024
Q3 		$620K Buy
113,900
+41,900
+58% +$276K ﹤0.01% 6816
2024
Q2 		$346K Buy
+72,000
New +$375K ﹤0.01% 7571
2022
Q1 		– Sell
-25,200
Closed -$183K – 10596
2021
Q4 		$183K Buy
+25,200
New +$249K ﹤0.01% 8881

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jane Street's HUMA Position: Q1 2026 in Review

Jane Street sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 518,918 shares — an estimated $539K sold.

Jane Street first reported a position in HUMA in Q1 2021 and held it in 15 quarters. The position peaked at $1.76M in Q4 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Jane Street reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 518,918 Humacyte shares in Q1 2026, an estimated $539K.
  • Jane Street first reported a position in Humacyte in Q1 2021 and held it in 15 quarters.
  • Jane Street's Humacyte position peaked at $1.76M in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.